Flower One Reports Q1-22 Financial Results
Ryan Allway July 23rd, 2022 News, Top News LAS VEGAS, July 23, 2022–(BUSINESS WIRE)–Flower One Holdings Inc. (“Flower One” or the “Company”) (CSE: FONE) (OTCQX: FLOOF) (FSE: F11), the leading cannabis cultivator and producer in Nevada, today announced its financial and operating results for the first quarter ended March... Read more
Canopy Growth Corporation (CGC) to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022
Flora Growth CEO Meets With Colombian Senator as Bill to Legalize Recreational Cannabis Is Introduced
Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that the Company met with the author of a new bill to legalize recreational cannabis on the day the legislation was introduced to Congress. Flora’s... Read more
TerrAscend Corp. (TRSSF) TO HOST SECOND QUARTER 2022 EARNINGS CONFERENCE CALL

TERRASCEND TO HOST SECOND QUARTER 2022 EARNINGS CONFERENCE CALL TerrAscend Corp. (“TerrAscend”…

The post TerrAscend Corp. (TRSSF) TO HOST SECOND QUARTER 2022 EARNINGS CONFERENCE CALL appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Skye Bioscience Selects NextPharma as Phase 2 Contract Drug Manufacturer
Ryan Allway July 21st, 2022 Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has selected NextPharma as its contract manufacturing organization (“CMO”) for its Phase 2 clinical trial material. NextPharma is a leading European pharmaceutical contract... Read more
LUFF ENTERPRISES to Acquire Licensed Producer as Next Step in Online Marketplace Strategy
Ryan Allway July 21st, 2022 Luff Enterprises Ltd., (CSE:LUFF) (“LUFF” or the “Company”) is pleased to announce the signing of a definitive agreement to acquire a licensed producer in British Columbia. Luff plans to acquire, largely for share consideration, the National Green Biomed group of companies (“NG Biomed”). NG Biomed... Read more
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
Ryan Allway July 21st, 2022 News, Top News BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it has entered into definitive agreements with... Read more
Ryan Allway July 21st, 2022 News, Top News Announces $35 Million Above Market Financing Bolsters Company’s Position with Ongoing Strategic Discussions BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis,... Read more
Albert Appointed to Board of Managers of LBS
Ryan Allway July 20th, 2022 News, Top News Lighthouse Biz Solutions, LLC (LBS), a wholly owned subsidiary of GFA Federal Credit Union is pleased to announce Salvatore (Sam) Albert has been elected to its Board of Managers. The Board of Managers establishes the strategic direction of this subsidiary and... Read more
Skye Bioscience Updates Phase 1 Timeline
Ryan Allway July 20th, 2022 News, Top News San Diego, California, July 20, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has been advised by its contract manufacturer (“CMO”) of its Phase... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )